13668-710-91 : NDC 2026 Code

13668-710-91 : Nilotinib ( Nilotinib )

Additionally :

You can get information about “13668-710-91” NDC code in 13668-710-91 in HTML format

HTML | 13668-710-91 in TXT (Plain Text) format

TXT | 13668-710-91 in PDF (Portable Document Format)

PDF | 13668-710-91 in XML format

XML formats.

NDC Code : 13668-710-91 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "13668-710-91",
    "PackageDescription": "1 BLISTER PACK in 1 CARTON (13668-710-91)  / 28 CAPSULE in 1 BLISTER PACK",
    "NDC11Code": "13668-0710-91",
    "ProductNDC": "13668-710",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Nilotinib",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Nilotinib",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20251216",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA218532",
    "LabelerName": "Torrent Pharmaceuticals Limited",
    "SubstanceName": "NILOTINIB HYDROCHLORIDE MONOHYDRATE",
    "StrengthNumber": "150",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-18",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251216",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}